Reagent kits required for provider/patient management of outpatient care.
Ended Awarded
- Contract number
- HT009025FG0830110
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $34,242
Award facts
- Contract value 100% obligated
- $34,241.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency (DHA) awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation on August 4, 2025, with a ceiling value of $34,241.82 for reagent kits required for provider and patient management of outpatient care. The contract is a firm fixed-price arrangement with no set-aside designation and is scheduled for ultimate completion on September 30, 2025. Performance will be conducted in Castleton, Indiana. As a child contract under a larger vehicle, this award leverages Roche Diagnostics' pre-negotiated pricing and established terms to efficiently procure diagnostic testing supplies for the federal healthcare system.
Roche Diagnostics Corporation, a foreign-owned global leader in in vitro diagnostic solutions, is well-established as a federal contractor across multiple federal healthcare agencies, including the DHA and Department of Veterans Affairs. The company holds numerous significant Indefinite Delivery Contracts and Blanket Purchase Agreements, primarily under General Services Administration Schedule contracts for laboratory analyzers and in vitro diagnostics. Through these contract vehicles, Roche supplies a comprehensive range of laboratory equipment, testing systems, reagents, and clinical diagnostic technologies that support disease detection and patient care across military and federal healthcare systems. This award represents a specific call order for reagent kits to support ongoing diagnostic testing capabilities within the DHA's outpatient care delivery infrastructure.
Quick answers
Who was awarded contract HT009025FG0830110?
HT009025FG0830110 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on August 4, 2025.
How much is contract HT009025FG0830110 worth?
The government has obligated $34,242 on HT009025FG0830110.
Is contract HT009025FG0830110 an order under another contract?
Yes. HT009025FG0830110 is a BPA call under FA301625A0005, a blanket purchase agreement.
Was contract HT009025FG0830110 competed?
The extent of competition for HT009025FG0830110 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award